Form 4 Filing for BIO-TECHNE Corp

This filing details transactions by James Hippel, CFO of BIO-TECHNE Corp (TECH), on April 22, 2026. Hippel acquired 62,000 shares of Common Stock through a derivative transaction (stock options) with a transaction price of $0.00. He also acquired 62,000 shares of Common Stock in a non-derivative transaction, also with a transaction price of $0.00. In a separate non-derivative transaction, 56,097 shares of Common Stock were disposed of at a price of $58.58 per share. Following these transactions, Hippel holds 204,722 shares directly. The filing also lists various derivative holdings, including stock options and restricted stock units, with different vesting schedules and exercise prices.